The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the ...

A magnitude 5.7 earthquake rattled Tibet early Monday at a shallow depth of 10km, as reported by the National Center for Seismology. This follows a smaller 3.7 magnitude quake just days prior in ...

Merck eyes deal with Afrigen Biologics In other mRNA vaccine news today, Germany’s Merck KGaA revealed that it has signed a non-binding memorandum of understanding with South Africa-based ...

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...

Novartis’ groundbreaking cancer T-cell therapy CTL019 has won unanimous backing from advisers to the FDA, paving the way for approval in the coming months. There had been concerns that the ...

Novartis' president of biomedical research. President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.